B-Tuss

Do not use this medicine if you have used an MAO inhibitor in the past 14 days, such as isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, selegiline, or tranylcypromine.

You should not use this medicine if you have recently used alcohol, sedatives, tranquilizers, or other narcotic medications.

This medication may cause blurred vision and may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert and able to see clearly.

Drinking alcohol can increase certain side effects of chlorpheniramine, hydrocodone, and phenylephrine.

Taking this medicine with other drugs that make you sleepy or slow your breathing can cause dangerous or life-threatening side effects. Ask your doctor before taking chlorpheniramine, hydrocodone, and phenylephrine with a sleeping pill, narcotic pain medicine, muscle relaxer, or medicine for anxiety, depression, or seizures.

Other drugs may interact with chlorpheniramine, hydrocodone, and phenylephrine, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.

Chlorpheniramine/hydrocodone/phenylephrine 2 mg-6 mg-12 mg/5 mL oral liquid:
5 to 10 mL orally every 4 to 6 hours not to exceed 50 mL daily.

Chlorpheniramine/hydrocodone/phenylephrine 2.5 mg-3.5 mg-8 mg/5 mL oral liquid:
Chlorpheniramine/hydrocodone/phenylephrine 2.5 mg-3.25 mg-8 mg/5 mL oral liquid:
10 mL orally every 4 to 6 hours not to exceed 40 mL daily.

Chlorpheniramine/hydrocodone/phenylephrine 3 mg-5 mg-7.5 mg/5 mL oral liquid:
5 to 10 mL orally every 4 to 6 hours not to exceed 40 mL daily.

Chlorpheniramine/hydrocodone/phenylephrine 2 mg-2.5 mg-10 mg/5 mL oral liquid:
10 mL orally every 4 to 6 hours not to exceed 40 mL daily.

Data not available

There are no data on the excretion of chlorpheniramine/hydrocodone/phenylephrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.